NEC OncoImmunity AS
Ioannis Vardaxis, PhD, is a Data Science Manager at NEC OncoImmunity AS since October 2018, with previous roles as Principal Data Scientist and Data Scientist at the same company. Prior to this, Ioannis Vardaxis was a PhD student in Biostatistics at NTNU from August 2014 to October 2018. Education includes a Doctor of Philosophy in Biostatistics from the Norwegian University of Science and Technology (NTNU), and participation as a visiting PhD student at Harvard T.H. Chan School of Public Health. Ioannis Vardaxis also holds a Master’s degree in Biostatistics from NTNU and a Bachelor’s degree in Mathematical Sciences with a focus on Statistics from the University of Heraklion, Crete.
This person is not in any teams
NEC OncoImmunity AS
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning software, which addresses the key gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines. We are dedicated to developing scalable software solutions that facilitate effective patient selection for cancer immunotherapy, and identifying optimal neoantigen targets for truly personalized cancer vaccines & cell therapies in a clinically actionable time frame. Our growing international team (13 countries and counting!) consists of a diverse mix of data scientists, bioinformaticians, immunologists, cancer researchers, and software developers. NEC OncoImmunity AS is a subsidiary of the NEC Corporation, and is based in the Oslo Cancer Cluster buildings in Oslo, Norway.